180 related articles for article (PubMed ID: 29287079)
1. Numerical modeling of nanodrug distribution in tumors with heterogeneous vasculature.
Chou CY; Chang WI; Horng TL; Lin WL
PLoS One; 2017; 12(12):e0189802. PubMed ID: 29287079
[TBL] [Abstract][Full Text] [Related]
2. Image-based spatio-temporal model of drug delivery in a heterogeneous vasculature of a solid tumor - Computational approach.
Moradi Kashkooli F; Soltani M; Rezaeian M; Taatizadeh E; Hamedi MH
Microvasc Res; 2019 May; 123():111-124. PubMed ID: 30711547
[TBL] [Abstract][Full Text] [Related]
3. Two-dimensional chemotherapy simulations demonstrate fundamental transport and tumor response limitations involving nanoparticles.
Sinek J; Frieboes H; Zheng X; Cristini V
Biomed Microdevices; 2004 Dec; 6(4):297-309. PubMed ID: 15548877
[TBL] [Abstract][Full Text] [Related]
4. Multifunctional nanoparticles for combining ultrasonic tumor imaging and targeted chemotherapy.
Rapoport N; Gao Z; Kennedy A
J Natl Cancer Inst; 2007 Jul; 99(14):1095-106. PubMed ID: 17623798
[TBL] [Abstract][Full Text] [Related]
5. Tumor targeting efficiency of bare nanoparticles does not mean the efficacy of loaded anticancer drugs: importance of radionuclide imaging for optimization of highly selective tumor targeting polymeric nanoparticles with or without drug.
Lee BS; Park K; Park S; Kim GC; Kim HJ; Lee S; Kil H; Oh SJ; Chi D; Kim K; Choi K; Kwon IC; Kim SY
J Control Release; 2010 Oct; 147(2):253-60. PubMed ID: 20624433
[TBL] [Abstract][Full Text] [Related]
6. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
7. Predicting drug delivery efficiency into tumor tissues through molecular simulation of transport in complex vascular networks.
Troendle EP; Khan A; Searson PC; Ulmschneider MB
J Control Release; 2018 Dec; 292():221-234. PubMed ID: 30415016
[TBL] [Abstract][Full Text] [Related]
8. Dextran-doxorubicin/chitosan nanoparticles for solid tumor therapy.
Bisht S; Maitra A
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2009; 1(4):415-25. PubMed ID: 20049807
[TBL] [Abstract][Full Text] [Related]
9. Bioreducible carboxymethyl dextran nanoparticles for tumor-targeted drug delivery.
Thambi T; You DG; Han HS; Deepagan VG; Jeon SM; Suh YD; Choi KY; Kim K; Kwon IC; Yi GR; Lee JY; Lee DS; Park JH
Adv Healthc Mater; 2014 Nov; 3(11):1829-38. PubMed ID: 24753360
[TBL] [Abstract][Full Text] [Related]
10. Hyperthermia-enhanced tumor accumulation and antitumor efficacy of a doxorubicin-conjugate with a novel macromolecular carrier system in mice with non-small cell lung cancer.
Oyama T; Kawamura M; Abiko T; Izumi Y; Watanabe M; Kumazawa E; Kuga H; Shiose Y; Kobayashi K
Oncol Rep; 2007 Mar; 17(3):653-9. PubMed ID: 17273747
[TBL] [Abstract][Full Text] [Related]
11. Two step mechanisms of tumor selective delivery of N-(2-hydroxypropyl)methacrylamide copolymer conjugated with pirarubicin via an acid-cleavable linkage.
Nakamura H; Etrych T; Chytil P; Ohkubo M; Fang J; Ulbrich K; Maeda H
J Control Release; 2014 Jan; 174():81-7. PubMed ID: 24269967
[TBL] [Abstract][Full Text] [Related]
12. Dextran-based doxorubicin nanocarriers with improved tumor penetration.
Sagnella SM; Duong H; MacMillan A; Boyer C; Whan R; McCarroll JA; Davis TP; Kavallaris M
Biomacromolecules; 2014 Jan; 15(1):262-75. PubMed ID: 24313925
[TBL] [Abstract][Full Text] [Related]
13. Drug delivery and transport to solid tumors.
Jang SH; Wientjes MG; Lu D; Au JL
Pharm Res; 2003 Sep; 20(9):1337-50. PubMed ID: 14567626
[TBL] [Abstract][Full Text] [Related]
14. A robust approach to enhance tumor-selective accumulation of nanoparticles.
Qiao Y; Huang X; Nimmagadda S; Bai R; Staedtke V; Foss CA; Cheong I; Holdhoff M; Kato Y; Pomper MG; Riggins GJ; Kinzler KW; Diaz LA; Vogelstein B; Zhou S
Oncotarget; 2011; 2(1-2):59-68. PubMed ID: 21378416
[TBL] [Abstract][Full Text] [Related]
15. Nanoparticles for targeted delivery of therapeutics and small interfering RNAs in hepatocellular carcinoma.
Varshosaz J; Farzan M
World J Gastroenterol; 2015 Nov; 21(42):12022-41. PubMed ID: 26576089
[TBL] [Abstract][Full Text] [Related]
16. Mathematical modeling of the heterogeneous distributions of nanomedicines in solid tumors.
He H; Liu C; Liu Y; Liu X; Wu Y; Fan J; Zhao L; Cao Y
Eur J Pharm Biopharm; 2019 Sep; 142():153-164. PubMed ID: 31226367
[TBL] [Abstract][Full Text] [Related]
17. Redox-responsive mesoporous silica nanoparticles: a physiologically sensitive codelivery vehicle for siRNA and doxorubicin.
Ma X; Teh C; Zhang Q; Borah P; Choong C; Korzh V; Zhao Y
Antioxid Redox Signal; 2014 Aug; 21(5):707-22. PubMed ID: 23931896
[TBL] [Abstract][Full Text] [Related]
18. Investigation of the spatiotemporal responses of nanoparticles in tumor tissues with a small-scale mathematical model.
Chou CY; Huang CK; Lu KW; Horng TL; Lin WL
PLoS One; 2013; 8(4):e59135. PubMed ID: 23565142
[TBL] [Abstract][Full Text] [Related]
19. Spatio-temporal investigation of doxorubicin in a 3D heterogeneous tumor microenvironment.
Shojaee P; Alinezhad L; Sefidgar M
Biomed Phys Eng Express; 2020 Mar; 6(3):035008. PubMed ID: 33438653
[TBL] [Abstract][Full Text] [Related]
20. Bioreducible shell-cross-linked hyaluronic acid nanoparticles for tumor-targeted drug delivery.
Han HS; Thambi T; Choi KY; Son S; Ko H; Lee MC; Jo DG; Chae YS; Kang YM; Lee JY; Park JH
Biomacromolecules; 2015 Feb; 16(2):447-56. PubMed ID: 25565417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
